Meta-analysis
Published: Apr 2018
ACE Report #10252
Ace Report Cover Metabolic Disorders

Larger BMD gains in osteoporosis patients transitioning to denosumab versus other active controls


Study Type:Meta-analysis/Systematic Review
OE Level Evidence:1
Journal Level of Evidence:N/A

Safety and efficacy of denosumab in osteoporotic patients previously treated with other medications: a systematic review and metaanalysis

Expert Opin Drug Saf. 2018 Apr;17(4):413-428

Contributing Authors: EI Kenanidis ME Potoupnis E Tsiridis A Fontalis E Prousali

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE

Please Login or Join to leave comments.